Study | Â | Baseline | Post-intervention | +3-months follow up | +6-month follow up | +12- months follow up | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | N | m/s (SD) | N | m/s (SD) | N | m/s (SD) | N | m/s (SD) | N | m/s (SD) | |
Halvarsson (2013) [53] | Intervention | 38 | 1.11 (0.23) | 34 | 1.19 (0.17) | - | - | 32 | 1.16 (0.19) | 30 | 1.15 (0.24) |
Control | 21 | 1.09 (0.22) | 21 | 1.10 (0.23) | - | - | 20 | 1.08 (0.22) | 18 | 1.02 (0.28) | |
Kim (2011) [42] | Intervention | 31 | 1.10 (0.30) | 30 | 1.10 (0.20) | 30 | 1.20 (0.20) | - | - | - | - |
Control | 30 | 1.20 (0.20) | 29 | 1.10 (0.20) | 29 | 1.10 (0.30) | - | - | - | - | |
Gine-Garriga 2013 | Intervention | 26 | 0.82 (0.19) | 22 | 0.94 (0.19) | - | - | 18 | 0.88 (0.19) | - | - |
Control | 25 | 0.82 (0.17) | 19 | 0.80 (0.17) | - | - | 7 | 0.81 (0.17) | - | - | |
Freiberger (2012) [32] | Intervention SB | 63 | 0.95 (0.22) | 57 | 0.92 (0.22) | - | - | 53 | 0.93 (0.22) | 49 | 0.98 (0.20) |
 | FG | 64 | 0.98 (0.18) | 57 | 1.00 (0.17) | - | - | 54 | 0.97 (0.19) | 48 | 1.03 (0.16) |
 | MG | 72 | 0.98 (0.20) | 69 | 0.95 (0.20) | - | - | 69 | 0.93 (0.20) | 57 | 0.93 (0.19) |
 | Control | 78 | 0.95 (0.27) | 70 | 0.97 (0.18) | - | - | 64 | 0.93 (0.20) | 51 | 0.95 (0.24) |